×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Rodman David Malcom

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
MLYSMineralys Therapeutics, Inc.Rodman David MalcomChief Medical OfficerFeb 12, 2024Option Exercise$0.8411,3669,56644,266Feb 13, 2024, 04:08 PM
MLYSMineralys Therapeutics, Inc.Rodman David MalcomChief Medical OfficerJan 11, 2024Option Exercise$0.545,0172,70926,552Jan 12, 2024, 04:01 PM
MLYSMineralys Therapeutics, Inc.Rodman David MalcomChief Medical OfficerJan 12, 2024Option Exercise$1.086,3486,85632,900Jan 12, 2024, 04:01 PM
MLYSMineralys Therapeutics, Inc.Rodman David MalcomChief Medical OfficerDec 11, 2023Option Exercise$0.545,0182,71020,069Dec 12, 2023, 05:08 PM
MLYSMineralys Therapeutics, Inc.Rodman David MalcomChief Medical OfficerNov 13, 2023Option Exercise$0.545,0172,70915,051Nov 14, 2023, 06:18 PM
MLYSMineralys Therapeutics, Inc.Rodman David MalcomChief Medical OfficerNov 03, 2023Option Exercise$0.5410,0345,41810,034Nov 07, 2023, 05:15 PM
MLYSMineralys Therapeutics, Inc.Rodman David MalcomChief Medical OfficerAug 10, 2023Option Exercise$6.85149,2501,022,36274,625Aug 11, 2023, 07:11 PM
MLYSMineralys Therapeutics, Inc.Rodman David MalcomChief Medical OfficerAug 11, 2023Option Exercise$6.81314,1822,138,30380,909Aug 11, 2023, 07:11 PM
NVLSNivalis Therapeutics, Inc.Rodman David MalcomExec Vice President and CMOJan 04, 2017Sale$2.276,68715,17911,368Jan 05, 2017, 11:00 AM
NVLSNivalis Therapeutics, Inc.Rodman David MalcomExec Vice President and CMOOct 04, 2016Sale$7.965,82046,32712,236Oct 05, 2016, 04:16 PM
NVLSNivalis Therapeutics, Inc.Rodman David MalcomExec Vice President and CMOJul 05, 2016Sale$4.665,95027,72712,105Jul 06, 2016, 04:15 PM